A 49-year-old woman presents with 6 months of symmetrical swelling and pain in the small joints of her hands and wrists, morning stiffness lasting over an hour and elevated inflammatory markers. Rheumatoid factor and anti-CCP antibodies are positive. What is the most appropriate initial disease-modifying pharmacological treatment?